Caitong International Asset Management Co., LTD Fate Therapeutics Inc Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 237 shares of FATE stock, worth $336. This represents 0.0% of its overall portfolio holdings.
Number of Shares
237
Previous 237
-0.0%
Holding current value
$336
Previous $391,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding FATE
# of Institutions
167Shares Held
108MCall Options Held
79.2KPut Options Held
9K-
Redmile Group, LLC San Francisco, CA12.9MShares$18.3 Million1.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$14.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$14.4 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.84MShares$6.87 Million0.16% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.38MShares$6.22 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $138M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...